BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18353123)

  • 1. Fibrinolytic therapy for intraventricular hemorrhage: is the answer becoming clear yet?
    Demaerschalk BM
    Eur J Neurol; 2008 Apr; 15(4):320-2. PubMed ID: 18353123
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraventricular hemorrhage: harmful effect is not from the pressure alone.
    Lee K; Claassen J
    Cerebrovasc Dis; 2009; 27(4):411-2. PubMed ID: 19295202
    [No Abstract]   [Full Text] [Related]  

  • 3. CLEAR: the intraventricular haemorrhage thrombolysis trial.
    Akhtar A; Kamal AK
    J Pak Med Assoc; 2013 Jul; 63(7):928. PubMed ID: 23901725
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraventricular tissue plasminogen activator for intraventricular hemorrhage caused by an arteriovenous malformation.
    Keefe K; Kebriaei M; Gard A; Patil AA
    J Clin Neurosci; 2014 Mar; 21(3):526-9. PubMed ID: 24134809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis for intraventricular hemorrhage.
    Wong RH; Bailes JE
    Semin Thromb Hemost; 2013 Jun; 39(4):400-5. PubMed ID: 23446915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombolytic therapy after intraventricular haemorrhage].
    Gadegaard KH; Dahl BL; Hansen TS
    Ugeskr Laeger; 2010 May; 172(19):1440-1. PubMed ID: 20470653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular thrombolysis for massive intraventricular hemorrhage due to periventricular arteriovenous malformations: no absolute contraindications as rescue therapy prior to surgical repair or embolization?
    Jorens PG; Menovsky TM; Voormolen MH; Van Den Brande E; Parizel PM
    Clin Neurol Neurosurg; 2009 Jul; 111(6):544-50. PubMed ID: 19328624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic therapy for intraventricular hemorrhage in adults.
    Lapointe M; Haines S
    Cochrane Database Syst Rev; 2002; 2002(3):CD003692. PubMed ID: 12137707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose intraventricular fibrinolytic treatment to prevent posthaemorrhagic hydrocephalus.
    Corrigan JJ
    Arch Dis Child; 1992 Jul; 67(7 Spec No):886. PubMed ID: 1519999
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter by Gaberel et Al regarding article, "dose effect of intraventricular fibrinolysis in ventricular hemorrhage".
    Gaberel T; Emery E; Vivien D
    Stroke; 2011 Sep; 42(9):e548-9; author reply e550. PubMed ID: 21817144
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of intraventricular thrombolytics in intraventricular hemorrhage.
    Nyquist P; Hanley DF
    J Neurol Sci; 2007 Oct; 261(1-2):84-8. PubMed ID: 17553525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study.
    Huttner HB; Tognoni E; Bardutzky J; Hartmann M; Köhrmann M; Kanter IC; Jüttler E; Schellinger PD; Schwab S
    Eur J Neurol; 2008 Apr; 15(4):342-9. PubMed ID: 18312407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legacy of MISTIE III.
    Sigounas D
    World Neurosurg; 2019 Jun; 126():589-590. PubMed ID: 31546318
    [No Abstract]   [Full Text] [Related]  

  • 14. What should a new thrombolytic bring us?
    Verheugt F
    Int J Clin Pract Suppl; 1998 Nov; 99():3-5. PubMed ID: 10344033
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolytic therapy after intraventricular hemorrhage: do we know enough?
    Carhuapoma JR
    J Neurol Sci; 2002 Oct; 202(1-2):1-3. PubMed ID: 12220685
    [No Abstract]   [Full Text] [Related]  

  • 16. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.
    Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; Narula R; Guo KH; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
    Neurosurgery; 2010 Apr; 66(4):648-55. PubMed ID: 20305489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy.
    Brott T
    Neurol Clin; 1992 Feb; 10(1):219-32. PubMed ID: 1557004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage.
    Fountas KN; Kapsalaki EZ; Parish DC; Smith B; Smisson HF; Johnston KW; Robinson JS
    South Med J; 2005 Aug; 98(8):767-73. PubMed ID: 16144170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraventricular tissue plasminogen activator toxicity.
    Gaberel T; Emery E
    Neurosurgery; 2011 Jan; 68(1):E288-9; author reply E289. PubMed ID: 21150745
    [No Abstract]   [Full Text] [Related]  

  • 20. Lower dose intraventricular T-PA fibrinolysis: case report.
    Deutsch H; Rodriguez JC; Titton RL
    Surg Neurol; 2004 May; 61(5):460-3; discussion 463. PubMed ID: 15120223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.